Dalfoni Banerjee Illustrates Drug Development Process at MBS Café
According to a 2024 Deloitte report, the world’s top 20 pharmaceutical companies collectively spent $145 billion in research and development (R&D) during 2022-2023. This substantial investment highlights the ongoing pursuit of innovation in medicine.